References
Li H, Chen G. Letter to Cell Death Pathways in Ischemic Stroke and Targeted Pharmacotherapy. Transl Stroke Res. 2021. https://doi.org/10.1007/s12975-021-00965-7. Epub ahead of print.
Datta A, Sarmah D, Mounica L, Kaur H, Kesharwani R, Verma G, et al. Cell death pathways in ischemic stroke and targeted pharmacotherapy. Transl Stroke Res. 2020;11(6):1185–202.
Kowalski RG, Haarbauer-Krupa JK, Bell JM, Corrigan JD, Hammond FM, Torbey MT, et al. Acute ischemic stroke after moderate to severe traumatic brain injury: incidence and impact on outcome. Stroke. 2017;48:1802–9.
Campbell BC, De Silva DA, Macleod MR, Coutts SB, Schwamm LH, Davis SM, et al. Ischaemic stroke Nat Rev Dis Primers. 2019;5:1–22.
Sarmah D, Kaur H, Saraf J, Pravalika K, Goswami A, Kalia K, et al. Getting closer to an effective intervention of ischemic stroke: the big promise of stem cell. Transl Stroke Res. 2018;9:356–74.
Chen S, Shao L, Ma L. Cerebral edema formation after stroke: emphasis on blood-brain barrier and the lymphatic drainage system of the brain. Front Cell Neurosci. 2021;15:716825.
Pemberton JM, Pogmore JP, Andrews DW. Neuronal cell life, death, and axonal degeneration as regulated by the BCL-2 family proteins. Cell Death Differ. 2021;28:108–22.
Claude-Taupin A, Jia J, Bhujabal Z, Garfa-Traore M, Kumar S, da Silva GPD, et al. ATG9A protects the plasma membrane from programmed and incidental permeabilization. Nat Cell Biol. 2021;23:846–58.
Sano R, Reed JC. ER stress-induced cell death mechanisms. Biochim Biophys Acta. 2013;1833:3460–70.
Sarmah D, Kaur H, Saraf J, Vats K, Pravalika K, Wanve M, et al. Mitochondrial dysfunction in stroke: implications of stem cell therapy. Transl Stroke Res. 2019;10:121–36.
Liu S, Fu S, Wang G, Cao Y, Li L, Li X, et al. Glycerol-3-phosphate biosynthesis regenerates cytosolic NAD(+) to alleviate mitochondrial disease. Cell Metab. 2021;33:1974-87.e9.
Jia J, Jin H, Nan D, Weiwei Y, Yining H. New insights into targeting mitochondria in ischemic injury. Apoptosis. 2021;26:163–183.
Bertheloot D, Latz E, Franklin BS. Necroptosis, pyroptosis and apoptosis: an intricate game of cell death. Cell Mol Immunol. 2021;18:1106–21.
Lin C-H, Chen M, Sun M-C. Circulating apoptotic factors in patients with acute cerebral infarction. Clin Biochem. 2010;43:761–3.
Inekci D, Linemann T, Ripova D, Henriksen K, Bartos A. Validation of a caspase-3 generated tau fragment as a serum biomarker of brain damage due to stroke: implications for Alzheimer’s disease. Alzheimers Dement. 2014;4:P654.
Wunderlich MT, Lins H, Skalej M, Wallesch C-W, Goertler M. Neuron-specific enolase and tau protein as neurobiochemical markers of neuronal damage are related to early clinical course and long-term outcome in acute ischemic stroke. Clin Neurol Neurosurg. 2006;108:558–63.
Hjalmarsson C, Bjerke M, Andersson B, Blennow K, Zetterberg H, Åberg ND, et al. Neuronal and glia-related biomarkers in cerebrospinal fluid of patients with acute ischemic stroke. J Cent Nerv Syst Dis. 2014;6(JCNSD):S13821.
Hu H-W, Chen Z-G, Liu J-G, Chen G. Role of hydrogen in traumatic brain injury: a narrative review. Med Gas Res. 2021;11:114.
Zhang Y, Li H, Li X, Wu J, Xue T, Wu J, et al. TMEM16F aggravates neuronal loss by mediating microglial phagocytosis of neurons in a rat experimental cerebral ischemia and reperfusion model. Front Immunol. 2020;11:1144.
Xue T, Sun Q, Zhang Y, Wu X, Shen H, Li X, et al. Phosphorylation at S548 as a functional switch of sterile alpha and TIR motif-containing 1 in cerebral ischemia/reperfusion injury in rats. Mol Neurobiol. 2021;58:453–69.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Ethics Approval
NA.
Conflict of Interest
The authors declare no competing interests.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Datta, A., Sarmah, D. & Bhattacharya, P. Response to Letter to Cell Death Pathways in Ischemic Stroke and Targeted Pharmacotherapy. Transl. Stroke Res. 13, 359–361 (2022). https://doi.org/10.1007/s12975-021-00967-5
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12975-021-00967-5